HB 2519

  • Oregon House Bill
  • 2017 Regular Session
  • Introduced in House Jan 09, 2017
  • House
  • Senate
  • Governor

Relating to the program used to monitor the dispensing of prescription drugs; declaring an emergency.

Abstract

Requires pharmacy to report de-identified information to prescription monitoring program upon dispensing prescribed naloxone. Requires pharmacy to report certain other identifying information to prescription monitoring program upon dispensing prescribed controlled substance classified in schedules II through IV. Requires information to be disclosed from prescription monitoring program to medical director or pharmacy director. Requires information to be disclosed from prescription monitoring program for certain other purposes. Requires licensing information of licensees who are authorized to prescribe or dispense controlled substances to be provided to Oregon Health Authority for purpose of qualifying licensees to report information to, or receive information from, prescription monitoring program. Becomes operative January 1, 2018. Declares emergency, effective on passage.

Bill Sponsors (5)

Votes


No votes to display

Actions


Jul 07, 2017

Oregon Legislative Assembly

In committee upon adjournment.

Jan 18, 2017

Oregon Legislative Assembly

Referred to Health Care.

Jan 09, 2017

Oregon Legislative Assembly

First reading. Referred to Speaker's desk.

Bill Text

Bill Text Versions Format
Introduced PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Oregon Legislative Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.